• PDF / 130,117 Bytes
• 8 Pages / 612.28 x 790.87 pts Page_size
• 26 Downloads / 220 Views

DOWNLOAD

REPORT

---

NEWS

ª 2009 Adis Data Information BV. All rights reserved.

Journal Watchy Contents 1. Biologic Therapy for Rheumatoid Arthritis: Clinical Efficacy and Predictors of Response . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201 2. Current Status and Challenges Associated with Targeting mTOR for Cancer Therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202 3. Targeted Therapies for Malignant Glioma: Progress and Potential . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 202 4. Thrombotic Microangiopathy in Hematopoietic Stem Cell Transplantation: Diagnosis and Treatment . . . . . . . . . . . . . . . . . . . . . . . 202 5. Panitumumab: In Metastatic Colorectal Cancer with Wild-Type KRAS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203 6. Dasatinib: In Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia . . . . . . . . . . . . 203 7. Trastuzumab: A Pharmacoeconomic Review of Its Use in Early Breast Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203 8. Emerging Chemotherapeutic Strategies and the Role of Treatment Stratification in Ewing Sarcoma . . . . . . . . . . . . . . . . . . . . . . . . 204 9. Molecularly Targeted Therapies for Pediatric Acute Myeloid Leukemia: Progress to Date . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 204 10. Effect of Race/Ethnicity on the Efficacy of Warfarin: Potential Implications for Prevention of Stroke in Patients with Atrial Fibrillation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 204 11. Platelet Activation, and Antiplatelet Targets and Agents: Current and Novel Strategies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205 12. Cytochrome P450 2D6 Genotyping: Potential Role in Improving Treatment Outcomes in Psychiatric Disorders . . . . . . . . . . . . . . . . 205 13. The Role of Phosphodiesterases in Schizophrenia: Therapeutic Implications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206 14. Genetic Testing and Sports Medicine Ethics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206 15. Spontaneous ADR Reports as a Trigger for Pharmacogenetic Research: A Prospective Observational Study in the Netherlands . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206 16. Role of Cytochrome P450 Polymorphisms in the Development of Pulmonary Drug Toxicity: A Case-Control Study in the Netherlands . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .